Promising drug can inhibit aggressive breast cancer
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
Medical Xpress
How colorectal cancer evades immunotherapy using a dual barrier
Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types of cancer. However, most patients…
New lab-made antibody matches IVIG effectiveness at lower doses in mice
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently FDA-approved for four diseases but widely prescribed o…
Disease of 1,000 faces shows how science is tackling immunity’s dark side
Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She saved her life by begging for one more test in an emergency room about to send her home, again, without answers.
There are more than 100 autoimmune diseases, and they mostly strike women. Here’s what to know
Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues.
Q&A: How to spark immune hotspots that attack tumors
Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary lymphoid-like structures (TLSs). These immune cell clusters are increasingly linked to improved outcomes and treatment responses…
Immune overreactions explained: How killer T cells turn against the body
Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body? There are instances where killer T cells—which are meant to precisely remove virus-infected cells—malfunction like overheated engines, attacking even healthy…
AI can speed antibody design to thwart novel viruses
Artificial intelligence (AI) and “protein language” models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according to a multi-institutional study led by researchers a…
Peanut patch treatment continues to help toddlers safely build tolerance over three years
New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) offers encouraging news for parents of young children with peanut allergies. A long-term study found that a peanut patch trea…
COVID-19 vaccination linked to reduced infections in children with eczema
Children with atopic dermatitis (AD), commonly known as eczema, may experience fewer infections and allergic complications if they receive the COVID-19 vaccine, according to new research presented at the 2025 American College of Allergy, Asthma and Imm…